702 related articles for article (PubMed ID: 26362282)
1. Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome.
Kasir R; Zakko S; Zakko P; Adler M; Lee A; Dhingra S; Guttermuth C
Dig Dis Sci; 2016 Mar; 61(3):846-51. PubMed ID: 26362282
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
[TBL] [Abstract][Full Text] [Related]
3. Does Carbohydrate Challenge Testing Predict Clinical Response in Small Intestinal Bacterial Overgrowth?
Long SK; Di Palma JA
South Med J; 2016 May; 109(5):296-9. PubMed ID: 27135726
[TBL] [Abstract][Full Text] [Related]
4. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.
Nucera G; Gabrielli M; Lupascu A; Lauritano EC; Santoliquido A; Cremonini F; Cammarota G; Tondi P; Pola P; Gasbarrini G; Gasbarrini A
Aliment Pharmacol Ther; 2005 Jun; 21(11):1391-5. PubMed ID: 15932370
[TBL] [Abstract][Full Text] [Related]
5. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of small intestinal bacterial vergrowth in irritable bowel syndrome.
Mann NS; Limoges-Gonzales M
Hepatogastroenterology; 2009; 56(91-92):718-21. PubMed ID: 19621689
[TBL] [Abstract][Full Text] [Related]
7. [The dietary features of diarrhea predominant irritable bowel syndrome patients with small intestinal bowel overgrowth].
Wei H; Liu ZJ; Wang K; Zheng W; Duan LP
Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):567-571. PubMed ID: 28789488
[No Abstract] [Full Text] [Related]
8. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
[TBL] [Abstract][Full Text] [Related]
9. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome.
Zhuang X; Tian Z; Luo M; Xiong L
BMC Gastroenterol; 2020 Jun; 20(1):187. PubMed ID: 32532214
[TBL] [Abstract][Full Text] [Related]
10. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
Rana SV; Sharma S; Kaur J; Sinha SK; Singh K
Digestion; 2012; 85(3):243-7. PubMed ID: 22472730
[TBL] [Abstract][Full Text] [Related]
11. [Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].
Łokieć K; Klupińska G; Walecka-Kapica E; Błońska A
Pol Merkur Lekarski; 2014 May; 36(215):307-10. PubMed ID: 24964506
[TBL] [Abstract][Full Text] [Related]
12. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test.
Low K; Hwang L; Hua J; Zhu A; Morales W; Pimentel M
J Clin Gastroenterol; 2010 Sep; 44(8):547-50. PubMed ID: 19996983
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.
Ning Y; Lou C; Huang Z; Chen D; Huang H; Chen L; Zhang B; Dai N; Zhao J; Zhen X
Hell J Nucl Med; 2016; 19(2):124-9. PubMed ID: 27331205
[TBL] [Abstract][Full Text] [Related]
14. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.
Ghoshal UC; Srivastava D; Ghoshal U; Misra A
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):753-60. PubMed ID: 24849768
[TBL] [Abstract][Full Text] [Related]
15. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.
Pimentel M; Chow EJ; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3503-6. PubMed ID: 11151884
[TBL] [Abstract][Full Text] [Related]
16. Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects.
Bae S; Lee KJ; Kim YS; Kim KN
J Korean Med Sci; 2015 Jun; 30(6):757-62. PubMed ID: 26028929
[TBL] [Abstract][Full Text] [Related]
17. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls.
Walters B; Vanner SJ
Am J Gastroenterol; 2005 Jul; 100(7):1566-70. PubMed ID: 15984983
[TBL] [Abstract][Full Text] [Related]
18. Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.
Jung SE; Joo NS; Han KS; Kim KN
J Korean Med Sci; 2017 Jun; 32(6):948-953. PubMed ID: 28480652
[TBL] [Abstract][Full Text] [Related]
19. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
Posserud I; Stotzer PO; Björnsson ES; Abrahamsson H; Simrén M
Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502
[TBL] [Abstract][Full Text] [Related]
20. The Lactulose Breath Test in Irritable Bowel Syndrome: Is It All Hot Air?
Burgell RE; Gibson PR
Dig Dis Sci; 2016 Mar; 61(3):655-7. PubMed ID: 26547755
[No Abstract] [Full Text] [Related]
[Next] [New Search]
